Literature DB >> 2971311

Role of right and left atrial dimensions for release of atrial natriuretic peptide in left-sided valvular heart disease and idiopathic dilated cardiomyopathy.

M Haass1, R Dietz, T A Fischer, R E Lang, W Kübler.   

Abstract

To evaluate the role of atrial dimensions for release of atrial natriuretic peptide (ANP), right and left atrial dimensions (cross-sections) were determined by 2-dimensional echocardiography in 50 patients with left-sided valvular heart disease or idiopathic dilated cardiomyopathy. All patients underwent right- and left-sided heart catheterization with measurement of central hemodynamics. Plasma samples for ANP were withdrawn from femoral vein (ANPv) and ascending aorta. An estimate of right and left meridional atrial wall stress was derived by multiplying cross-sectional areas with pressures of the respective atria. As expected ANPv was closely related to mean right (r = 0.63; p less than 0.001; n = 50) and left atrial pressures (r = 0.61; p less than 0.001; n = 47). Furthermore, a positive correlation between ANPv and right (r = 0.56; p less than 0.001; n = 48) and left (r = 0.30; p less than 0.05; n = 48) atrial cross-sections was obtained. Finally, an excellent relation was found between ANPv and right (r = 0.73; p less than 0.001; n = 48) as well as left (r = 0.58; p less than 0.001; n = 44) meridional atrial wall stress, indicating that atrial wall stress rather than atrial pressures or dimensions alone determines plasma ANP concentrations. However, for identical right and left meridional atrial wall stress 3- to 4-times higher plasma ANPv levels were obtained in patients with idiopathic dilated cardiomyopathy than in patients with left-sided valvular heart disease. This indicates that release of ANP to the same stimulus may be modulated by the nature of the underlying heart disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2971311     DOI: 10.1016/0002-9149(88)91219-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  The effect of iron overload in the hearts of patients with beta-thalassemia.

Authors:  S V Brili; A I Tzonou; S S Castelanos; C J Aggeli; C A Tentolouris; C E Pitsavos; P K Toutouzas
Journal:  Clin Cardiol       Date:  1997-06       Impact factor: 2.882

2.  Plasma concentrations of atrial natriuretic peptide during physical exercise in patients with congestive heart failure.

Authors:  M Haass; R Dietz; J Purgaj; R E Lang; W Kübler
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

3.  Atrial natriuretic peptide and cyclic guanosine monophosphate plasma concentrations in patients with thyrotoxicosis and atrial fibrillation. Effect of short-term methimazole therapy.

Authors:  S Czekalski; K Widecka; J Gozdzik; K Ciechanowski; B Krzyzanowska-Swiniarska; E Gromniak; M Gruszczynska
Journal:  J Endocrinol Invest       Date:  1994-05       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.